Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA

BACKGROUND: Many guideline-eligible heart failure (HF) patients do not receive a survival benefit from implantable cardioverter defibrillators (ICDs). Improved risk stratification may help to reduce costs and improve the cost effectiveness of ICDs. OBJECTIVE: To estimate the potential outcomes, cost...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Day, Ken, Levy, Wayne C., Johnson, Meridith, Jacobson, Arnold F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871910/
https://www.ncbi.nlm.nih.gov/pubmed/26975999
http://dx.doi.org/10.1007/s40258-016-0234-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871910/
https://www.ncbi.nlm.nih.gov/pubmed/26975999
http://dx.doi.org/10.1007/s40258-016-0234-5

Ejemplares similares